Endocrine Society GUIDELINES Bundle (free trial)

Testosterone Therapy in Men with Hypogonadism

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/302958

Contents of this Issue

Navigation

Page 14 of 17

15 Table 7. Potential Adverse Effects of T Replacement Buccal T tablets • Alterations in taste • Irritation of gums Pellet implants • Infection, expulsion of pellet T nasal gel • Rhinorrhea, epistaxis, nasal discomfort, nasal congestion, parosmia Oral tablets (methylT)—not recommended • Effects on liver and cholesterol b a e mechanism of cough, which has been reported rarely aer intramuscular injections of T undecanoate and even more rarely aer T enanthate and cypionate, is unknown, but it has been attributed to pulmonary oil microembolization. b Liver toxicity has been reported mostly with oral 17α-alkylated androgens. Adapted with permission from Bhasin et al. J Clin Endocrinol Metab. 2010;95(6): 2536–2559. (cont'd)

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Testosterone Therapy in Men with Hypogonadism